IL18 and carcinoid tumor: With regard to somatostatin analogs and interferon, in 36 patients with metastatic or unresectable carcinoid tumors (65), treatment with PEG interferon + depot Octreotide was associated with a significant increase in plasma Interleukin 18 (IL-18) and a significant reduction in plasma bFGF.